Issue Brief

Price transparency Graphic

07/25/25

White House Artificial Intelligence Action Plan: Key Findings & Policy Actions

On July 23, 2025, the White House Office of Science and Technology Policy (OSTP) released “Winning the AI Race: America’s AI Action Plan.” In general, the Plan emphasizes the need for federal policy to enable rapid industry innovation, particularly in the face of escalating competition with China. The Plan links technological advancement to economic competitiveness and national security.

Price transparency Graphic

07/18/25

CMS CY 2026 Medicare Proposed Payment Rules: Digital Health Provisions

During the week of July 14, 2025, CMS issued its two annual rules that update payments to physicians and hospitals participating in the Medicare program for the next year: the CY 2026 Physician Fee Schedule (PFS) Proposed Rule and the CY 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center Proposed Rule). This issue brief examines only those changes specific to telehealth, digital health, and potential future payment pathways under the two proposed rules.

Price transparency Graphic

07/13/25

Analysis of Patient & Caregiver Organizations’ CMS Health Tech RFI Responses

On May 13, 2025, CMS and ASTP/ONC released a 26-page Request for Information (RFI), asking the public how the federal government can use technology to transform the healthcare ecosystem and advance HHS’ commitment to Make America Healthy Again. Maverick reviewed responses from patient and caregiver organizations that cited fragmented, inaccessible data as a barrier to meaningful use of digital health tools.

Price transparency Graphic

06/22/25

CMS Health Tech Modernization RFI Response Analysis

On May 13, 2025, CMS and ASTP/ONC released a 26-page Request for Information (RFI), asking the public how the federal government can use technology to modernize the healthcare ecosystem. The RFI is further evidence of a highly technology-focused HHS team.

Price transparency Graphic

06/1/25

FAQs: The National Academy of Medicine’s Artificial Intelligence Code of Conduct

The National Academy of Medicine (NAM) published “An Artificial Intelligence Code of Conduct for Health and Medicine,” (AICC) as a guide for responsible AI development and use in health care. The AICC aligns existing principles from academic, industry, and governmental agencies into a shared set of values and commitments.

Executive Order_adobe_express

05/25/25

The Make America Healthy Again (MAHA) Commission’s Assessment on Childhood Chronic Disease

On May 22, 2025, the Make America Healthy Again (MAHA) Commission released a 68-page report on childhood chronic disease trends in the U.S. The report will serve as a framework for reshaping the federal government’s response to chronic disease, advocating for a more holistic approach to public health and individual well-being.

Price transparency Graphic

05/15/25

CMS’ Request for Information: Health Technology Ecosystem

On May 13, 2025, CMS released a 26-page Request for Information (RFI), asking the public how the federal government can support digital health technology to advance HHS’ commitment to Make America Healthy Again.

Price transparency Graphic

04/4/25

Industry-led AI Governance: Emerging Frameworks

In the absence of coordinated federal action, private stakeholders are determining how best to govern health AI solutions. This brief examines four industry-developed frameworks for assessing AI and large language models (LLMs) in healthcare.

Price transparency Graphic

01/20/25

FAQs: FDA Draft Guidance on Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products

On January 6, 2025, the FDA released a 23-page draft guidance on the use of artificial intelligence (AI) in regulatory decision-making for drugs and biological products.

Price transparency Graphic

01/19/25

FAQs: FDA Draft Guidance on AI-Enabled Medical Devices

On January 6, 2025, the FDA released a 67-page draft guidance to explain what the agency will be looking for in AI products submitted for regulatory review as a medical device. It includes regulatory expectations related to labeling, post-market performance monitoring, and the use of model cards for transparency.